InsiderTrades

Form 4 for IRMD IRADIMED CORP

Accepted 2022-02-17 00:00:00 ET · period of report 2022-02-15 · accession 0000898432-22-000119 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-02-17 2022-02-15 IRMD HAWKINS JAMES B Dir A - Grant $1.48 +9,441 30.9K +44% +$14.0K
D 2022-02-17 2022-02-15 IRMD HAWKINS JAMES B Dir S - Sale $50.22 -9,441 21.5K -31% -$474.1K
D 2022-02-17 2022-02-15 IRMD HAWKINS JAMES B Dir M - OptEx $0.00 -9,441 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-02-15 A A 9,441 $1.48 30,931 D — — (F1) This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date.
2 Common Common Stock 2022-02-15 S D 9,441 $50.22 21,490 D — — (F2) This transaction was executed in multiple trades at prices ranging from $50.20 to $50.34. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
3 Derivative Stock Options (Right to Buy) 2022-02-15 M D 9,441 $0.00 0 D $1.48 · — to 2023-12-31 9,441 Common Stock (F1) This option, representing a right to purchase a total of 140,000 shares, was granted on 12-31-2013 and vested over 4 years in equal annual installments commencing on the first anniversary of the grant date.